These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
91 related articles for article (PubMed ID: 24997578)
1. Design and synthesis of CHAP31, trapoxin B and HC-toxin based bicyclic tetrapeptides disulfide as potent histone deacetylase inhibitors. Hoque MA; Islam MN; Islam MS; Kato T; Nishino N; Ito A; Yoshida M Bioorg Med Chem; 2014 Aug; 22(15):3850-5. PubMed ID: 24997578 [TBL] [Abstract][Full Text] [Related]
2. Bicyclic tetrapeptides as potent HDAC inhibitors: effect of aliphatic loop position and hydrophobicity on inhibitory activity. Islam MN; Islam MS; Hoque MA; Kato T; Nishino N; Ito A; Yoshida M Bioorg Med Chem; 2014 Aug; 22(15):3862-70. PubMed ID: 25022972 [TBL] [Abstract][Full Text] [Related]
3. Retraction notice to 'Design and synthesis of CHAP31, trapoxin B and HC-toxin based bicyclic tetrapeptides disulfide as potent histone deacetylase inhibitors' [Bioorg Med Chem 22 (2014) 3850-3855]. Bioorg Med Chem; 2015 Aug; 23(15):5078. PubMed ID: 26425745 [No Abstract] [Full Text] [Related]
4. Design and synthesis of mono and bicyclic tetrapeptides thioester as potent inhibitor of histone deacetylases. Hoque MA; Islam MS; Islam MN; Kato T; Nishino N; Ito A; Yoshida M Amino Acids; 2014 Oct; 46(10):2435-44. PubMed ID: 25048030 [TBL] [Abstract][Full Text] [Related]
5. FK228 (depsipeptide) as a natural prodrug that inhibits class I histone deacetylases. Furumai R; Matsuyama A; Kobashi N; Lee KH; Nishiyama M; Nakajima H; Tanaka A; Komatsu Y; Nishino N; Yoshida M; Horinouchi S Cancer Res; 2002 Sep; 62(17):4916-21. PubMed ID: 12208741 [TBL] [Abstract][Full Text] [Related]
6. Histone deacetylase as a new target for cancer chemotherapy. Yoshida M; Furumai R; Nishiyama M; Komatsu Y; Nishino N; Horinouchi S Cancer Chemother Pharmacol; 2001 Aug; 48 Suppl 1():S20-6. PubMed ID: 11587361 [TBL] [Abstract][Full Text] [Related]
7. Cyclic tetrapeptides bearing a sulfhydryl group potently inhibit histone deacetylases. Nishino N; Jose B; Okamura S; Ebisusaki S; Kato T; Sumida Y; Yoshida M Org Lett; 2003 Dec; 5(26):5079-82. PubMed ID: 14682769 [TBL] [Abstract][Full Text] [Related]
8. The first biologically active synthetic analogues of FK228, the depsipeptide histone deacetylase inhibitor. Yurek-George A; Cecil AR; Mo AH; Wen S; Rogers H; Habens F; Maeda S; Yoshida M; Packham G; Ganesan A J Med Chem; 2007 Nov; 50(23):5720-6. PubMed ID: 17958342 [TBL] [Abstract][Full Text] [Related]
9. Cyclic tetrapeptides with thioacetate tails or intramolecular disulfide bridge as potent inhibitors of histone deacetylases. Hoque MA; Arai T; Nishino N; Kim HJ; Ito A; Yoshida M Bioorg Med Chem Lett; 2012 Nov; 22(21):6770-2. PubMed ID: 23021104 [TBL] [Abstract][Full Text] [Related]
10. [Synthetic Study on Bicyclic Depsipeptides Containing an Intramolecular Disulfide Bond]. Narita K Yakugaku Zasshi; 2022; 142(9):917-926. PubMed ID: 36047217 [TBL] [Abstract][Full Text] [Related]
11. Cyclic tetrapeptides with -SS- bridging between amino acid side chains for potent histone deacetylases' inhibition. Arai T; Ashraful Hoque M; Nishino N; Kim HJ; Ito A; Yoshida M Amino Acids; 2013 Oct; 45(4):835-43. PubMed ID: 23754115 [TBL] [Abstract][Full Text] [Related]
12. Evaluation of functional groups on amino acids in cyclic tetrapeptides in histone deacetylase inhibition. Islam MS; Bhuiyan MP; Islam MN; Nsiama TK; Oishi N; Kato T; Nishino N; Ito A; Yoshida M Amino Acids; 2012 Jun; 42(6):2103-10. PubMed ID: 21638021 [TBL] [Abstract][Full Text] [Related]
13. Macrocyclic Octapeptide Binding and Inferences on Protein Substrate Binding to Histone Deacetylase 6. Watson PR; Gupta S; Hosseinzadeh P; Brown BP; Baker D; Christianson DW ACS Chem Biol; 2023 Apr; 18(4):959-968. PubMed ID: 37027789 [TBL] [Abstract][Full Text] [Related]
14. Cyclic hydroxamic-acid-containing peptide 31, a potent synthetic histone deacetylase inhibitor with antitumor activity. Komatsu Y; Tomizaki KY; Tsukamoto M; Kato T; Nishino N; Sato S; Yamori T; Tsuruo T; Furumai R; Yoshida M; Horinouchi S; Hayashi H Cancer Res; 2001 Jun; 61(11):4459-66. PubMed ID: 11389076 [TBL] [Abstract][Full Text] [Related]
15. New macrocyclic analogs of the natural histone deacetylase inhibitor FK228; design, synthesis and preliminary biological evaluation. Ni M; Esposito E; Raj VP; Muzi L; Zunino F; Zuco V; Cominetti D; Penco S; Dal Pozzo A Bioorg Med Chem; 2015 Nov; 23(21):6785-93. PubMed ID: 26481659 [TBL] [Abstract][Full Text] [Related]
16. Interaction of aliphatic cap group in inhibition of histone deacetylases by cyclic tetrapeptides. Nishino N; Shivashimpi GM; Soni PB; Bhuiyan MP; Kato T; Maeda S; Nishino TG; Yoshida M Bioorg Med Chem; 2008 Jan; 16(1):437-45. PubMed ID: 17900911 [TBL] [Abstract][Full Text] [Related]
17. Novel N-hydroxyfurylacrylamide-based histone deacetylase (HDAC) inhibitors with branched CAP group (Part 2). Feng T; Wang H; Su H; Lu H; Yu L; Zhang X; Sun H; You Q Bioorg Med Chem; 2013 Sep; 21(17):5339-54. PubMed ID: 23820574 [TBL] [Abstract][Full Text] [Related]
18. Chlamydocin analogs bearing carbonyl group as possible ligand toward zinc atom in histone deacetylases. Bhuiyan MP; Kato T; Okauchi T; Nishino N; Maeda S; Nishino TG; Yoshida M Bioorg Med Chem; 2006 May; 14(10):3438-46. PubMed ID: 16439135 [TBL] [Abstract][Full Text] [Related]
19. Total synthesis of burkholdacs A and B and 5,6,20-tri-epi-burkholdac A: HDAC inhibition and antiproliferative activity. Fukui Y; Narita K; Dan S; Yamori T; Ito A; Yoshida M; Katoh T Eur J Med Chem; 2014 Apr; 76():301-13. PubMed ID: 24589486 [TBL] [Abstract][Full Text] [Related]
20. Structure, histone deacetylase, and antiprotozoal activities of apicidins B and C, congeners of apicidin with proline and valine substitutions. Singh SB; Zink DL; Liesch JM; Dombrowski AW; Darkin-Rattray SJ; Schmatz DM; Goetz MA Org Lett; 2001 Sep; 3(18):2815-8. PubMed ID: 11529764 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]